Femasys (FEMY) Change in Account Payables (2020 - 2026)
Femasys (FEMY) posted Change in Account Payables of -$253439.0 for Q1 2026, up 21.19% on a QoQ basis from -$321574.0 in Q4 2025, and down 128.45% year-over-year from $890678.0 in Q1 2025.
Femasys (FEMY) Change in Account Payables (2020 - 2026) Analysis & Trends
Femasys' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$253439.0 for Q1 2026.
- Quarterly Change in Account Payables fell 128.45% year-over-year to -$253439.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$809288.0 (down 165.48% YoY) and the FY2025 annual result came in at $334829.0, up 61.38% from the prior year.
- Change in Account Payables was -$253439.0 for Q1 2026 at Femasys, up from -$321574.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $890678.0 in Q1 2025 and bottomed at -$1.1 million in Q3 2025.
- A 5-year average of $57716.0 and a median of $33103.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables jumped 1228.6% — and 2024, when it plunged 4667.41%.
- Femasys' Change in Account Payables stood at $114685.0 in 2022, then jumped by 149.33% to $285946.0 in 2023, then retreated by 9.33% to $259280.0 in 2024, then slumped by 224.03% to -$321574.0 in 2025, then increased by 21.19% to -$253439.0 in 2026.
- Business Quant data shows FEMY's Change in Account Payables at -$253439.0 in Q1 2026, -$321574.0 in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | -253,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -253,439.00 |
| Mar 31, 2026 | -253,439.00 |
| Dec 31, 2025 | -321,574.00 |
| Dec 31, 2025 | -321,574.00 |
| Sep 30, 2025 | -1.10 Mn |
| Sep 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | 867,484.00 |
| Jun 30, 2025 | 867,484.00 |
| Mar 31, 2025 | 890,678.00 |
| Mar 31, 2025 | 890,678.00 |
| Dec 31, 2024 | 259,280.00 |
| Dec 31, 2024 | 259,280.00 |
| Sep 30, 2024 | 171,883.00 |
| Sep 30, 2024 | 171,883.00 |
| Jun 30, 2024 | -85,929.00 |
| Jun 30, 2024 | -85,929.00 |
| Mar 31, 2024 | -137,753.00 |
| Mar 31, 2024 | -137,753.00 |
| Dec 31, 2023 | 285,946.00 |
| Dec 31, 2023 | 285,946.00 |